Analysts’ updated eps estimates for Monday, June 6th: Absci (NASDAQ:ABSI) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Absci Corporation is the AI-powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. The company’s Creation(TM) Platform involved in discovery […]